Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $58.88 million versus the consensus estimate of $49.4 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.